$BONU - News-> BioNeutral Announces Agreement With Nyco

New Post Public Reply Private Reply Replies (0) Message Board
PYCKtradr PYCKtradr #27671
$BONU - News-> BioNeutral Announces Agreement With Nyco Products Company for Distribution of a Ready to Use Sterilant to Long Term Care Markets
NEWARK, NJ(eTeligis Inc.)NEWARK, NJ, United States, via eTeligis Inc., 06/11/2014 -8:03 ET - BioNeutral Group, Inc. (PINKSHEETS:BONU) (OTC Pink: BONU) announced that it has entered into a Sales and Distribution Agreement with Nyco Products Company (Nyco) in Countryside, Illinois, to distribute BioNeutral's YGIENE 206 Sterilant for advanced infection control. Nyco is a respected manufacturer and distributor of cleaners, disinfectants and sanitizers for janitorial, hospitality, long term care, MRO, and food service. YGIENE 206 adds a superior level of infection control to Nyco's product offering in these markets.

BioNeutral's patent-pending YGIENE 206 is EPA registered and engineered to be a cleaner, disinfectant, and hospital grade sporacide/sterilant on hard, non-porous surfaces. Its rapid surface sterilization makes it particularly effective for hospital, medical, terminal, and long term care environments. YGIENE 206 kills most organisms in 90 to 120 seconds and all microbial life within 20 minutes of contact time. It is ideally suited for sterilizing surgical tables and non-invasive equipment, and for disinfecting and sterilizing areas where patients with infectious diseases have been treated.

The partnership between Nyco and BioNeutral will be advantageous for customers of both companies. YGIENE 206 brings additional efficacy in infection control to Nyco's product offering, while Nyco provides exceptional support in sales and customer training, plus critical exposure to a national distribution network for BioNeutral. According to Ray Dunning, Sr. Vice President of Sales for BioNeutral, "Nyco's ability to offer us direct and immediate national access to long term health care markets and other specialty channels is extremely attractive. Without question, Nyco is the type of company with whom we want to be associated. Their commitment to innovation in cleaning and disinfecting along with their industry leadership and longevity make them an ideal distributor partner for BioNeutral."

"We're very excited to team up with BioNeutral to be able to offer our customers amazing solutions that have the potential to reduce healthcare associated infections (HAIs) in hospitals and other healthcare facilities," stated Bob Stahurski, President and CEO of Nyco Products Company. "A one-step non-chlorine bleach alternative sterilant that kills all mircoorganisms within 20 minutes could highly impact disinfection procedures and protocols for the healthcare market. One key reason we chose to partner with BioNeutral is because YGIENE 206 does not have the adverse patient reactions associated with chlorine and bleach based products."

About Nyco Products Company

Nyco Products Company is a specialty manufacturer of high performance national cleaning brands and private branded chemicals used in the sanitary maintenance, healthcare, hospitality, food service, industrial, institutional and other cleaning markets. Founded in 1920, Nyco has a rich history of leadership and innovation in their industry, and is committed to delivering safe and healthy cleaning and disinfecting products with a high degree of efficacy. Nyco is a co-founding member of ChemBlend International LLC (CBI), a strategic alliance of specialty chemical blenders in North America. Visitwww.nycoproducts.comfor additional information on Nyco.

About BioNeutral Group, Inc.

Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is a specialty technology-based life-science company that has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, YGIENE and OGIENE, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the YGIENE brand have been approved by the EPA for sale in the United States. For more information on BioNeutral, including a listing of company products, leadership and background please visitwww.bioneutral.com.

CONTACTS:FOR THE COMPANY:Mark LowenthalCEOBioNeutral Group, Inc.+1-973-577-8003 Craig FisherS.T.A.T Group LLC+1-786-375-0556

SOURCE: BioNeutral Group, Inc.

http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Tachyus Partners with Anschutz for Enhanced Carbon Management

Updated Category News Views 169

Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...

Continue Reading
Cypress Creek Renewable's New Solar Initiative in Colorado

Updated Category News Views 270

Cypress Creek Renewables Expands Solar Capacity Cypress Creek Renewables, a leader in solar energy and storage project development, has recently achieved a significant milestone with the financial closure of its Sundance Solar and Energy Storage project. This hybrid solar initiative, located in Colorado, boasts a remarkable 75MWac solar capacity along with an impressive...

Continue Reading
Acrivon Therapeutics Unveils Key Data at Two Major Conferences

Updated Category News Views 32

Acrivon Therapeutics Showcases AP3 Platform at Leading Conferences Acrivon Therapeutics, Inc. is set to demonstrate its innovative AP3 platform at two prominent scientific conferences within the upcoming days. This promising platform plays a pivotal role in the streamlined drug discovery and clinical advancement, particularly for its leading candidates, ACR-368 and...

Continue Reading
Nokia Corporation Reports Strong Performance in Q3 2025

Updated Category News Views 410

Nokia Corporation's Q3 2025 Interim Report Overview Nokia Corporation delivered an impressive performance in its third-quarter report, demonstrating significant net sales growth and operational stability. This report highlights the notable achievements and strategic initiatives undertaken by Nokia, outlining its path towards sustaining growth amid a competitive landscape....

Continue Reading
Home Fire Sprinklers: Cost-Effective Safety Solutions

Updated Category News Views 134

How Home Fire Sprinklers Can Lower Construction Costs and Save Lives Home fire sprinklers play a vital role in improving safety and protecting lives in residential properties, while also significantly lowering construction expenses. These modern systems offer a range of benefits when incorporated into new building projects. Cost Savings with Fire Sprinklers By installing...

Continue Reading